Cardiovascular information system (CVIS) is a system that makes it easy to put together and send out reports and gives on-demand access to pictures, reports, and waveforms from cardiovascular electronic medical records (EMR). CVIS is used for catheterization, echocardiography, handling of electrocardiography (ECG) data, and vascular solutions. Since more people are developing cardiovascular illnesses (CVDs), the market for cardiovascular information systems is expected to expand over the next years. The increasing use of structured reporting is projected to aid in the market's expansion. All cardiac procedures and modalities have some sort of organized reporting in the majority of CVIS systems.
The global market for Cardiovascular Information Systems is anticipated to expand at a CAGR of 7.6% over the following several years.
Leading Companies in the Cardiovascular Information System Industry:
McKesson Corporation
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. It was founded in 1833 and headquartered in Texas, United States. It has international offices in Australia, Ireland, France, the Netherlands, and the United Kingdom. McKesson Corporation announced in September 2022 that it had signed a preliminary agreement to extend its partnership with CVS Health to distribute pharmaceuticals to mail-order and specialty pharmacies, retail pharmacies, and distribution centers through June 2027.
GE Healthcare
GE Healthcare is an American multinational medical technology company, was founded in1994 and headquartered in Illinois, U.S. It operates in more than 100 countries. In Mar 2023, the American College of Cardiology (ACC) and the World Heart Federation hosted the ACC.23/WCC conference and GE HealthCare showcased its most recent technologies and innovations for use during the crucial planning and intervention steps in the cardiology care pathway. The highlighted technologies and partnerships allow for a streamlined cardiology care pathway with integrated solutions that may shorten the interval between diagnosis and treatment, leverage data and artificial intelligence (AI) to offer useful insights, and ultimately contribute to health improvement.
Koninklijke Philips N.V.
Koninklijke Phillips N.V. is Dutch multinational conglomerate corporation, was founded in 1891 and headquartered in Amsterdam, Netherlands. It operates across 100 countries. In May 2023, at EuroPCR 2023, Philips exhibited its most recent portfolio of cardiology innovations that provide clinical confidence and efficiency in treating cardiac disease.
